Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53.9M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$32.1M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$27.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$20.1M |
| 5 |
M&T Bank
MTB
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$93.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$71.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$42.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Financials | 11.75% |
| 3 | Industrials | 10.85% |
| 4 | Healthcare | 10.32% |
| 5 | Consumer Discretionary | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XYZ
1601
PUT
Block Inc
XYZ
$49.4B
| $484K | 0.01% |
7,700
+700
| +10% | +$43.2K |
|
1602
Apogee Enterprises
APOG
$856M
| $483K | 0.01% |
10,856
+5,421
| +100% | +$244K |
|
|
DEA
1603
Easterly Government Properties
DEA
$1.18B
| $483K | 0.01% |
13,534
-44,329
| -77% | -$1.72M |
|
1604
RPC Inc
RES
$1.37B
| $482K | 0.01% |
54,253
-38,914
| -42% | -$351K |
|
1605
PUT
e.l.f. Beauty
ELF
$6.23B
| $481K | 0.01% |
+8,700
| New | +$426K |
|
|
BNY
1606
PUT
Bank of New York Mellon
BNY
$110B
| $480K | 0.01% |
+10,500
| New | +$450K |
|
1607
PUT
Bank of Montreal
BMO
$121B
| $480K | 0.01% |
5,300
+3,000
| +130% | +$278K |
|
|
SPR
1608
PUT
DELISTED
Spirit AeroSystems
SPR
| $480K | 0.01% |
16,200
-1,000
| -6% | -$26K |
|
1609
Novavax
NVAX
$1.56B
| $479K | 0.01% |
46,624
+7,694
| +20% | +$136K |
|
1610
CALL
Teradyne
TER
$57.1B
| $479K | 0.01% |
5,500
-1,600
| -23% | -$137K |
|
1611
Ameresco
AMRC
$1.12B
| $476K | 0.01% |
+8,338
| New | +$508K |
|
1612
Alphabet (Google) Class C
GOOG
$4.2T
| $476K | 0.01% |
+5,360
| New | +$512K |
|
|
NOVA
1613
DELISTED
Sunnova Energy
NOVA
| $476K | 0.01% |
26,454
-119,347
| -82% | -$2.4M |
|
1614
CALL
Expedia Group
EXPE
$40.3B
| $475K | 0.01% |
5,400
+1,500
| +38% | +$142K |
|
1615
OrthoPediatrics
KIDS
$646M
| $475K | 0.01% |
11,952
-7,755
| -39% | -$323K |
|
1616
PUT
Commercial Metals
CMC
$7.26B
| $473K | 0.01% |
9,800
-200
| -2% | -$9.17K |
|
1617
PUT
Capital One
COF
$133B
| $473K | 0.01% |
5,100
+800
| +19% | +$78.7K |
|
1618
PUT
Robert Half
RHI
$4.57B
| $472K | 0.01% |
6,400
-1,600
| -20% | -$122K |
|
1619
CALL
Darling Ingredients
DAR
$9.36B
| $470K | 0.01% |
7,500
+1,900
| +34% | +$134K |
|
|
GRMN
1620
PUT
Garmin
GRMN
$55.5B
| $470K | 0.01% |
5,100
-2,200
| -30% | -$194K |
|
1621
Hamilton Lane
HLNE
$4.53B
| $470K | 0.01% |
+7,354
| New | +$489K |
|
1622
Accuray
ARAY
$33.2M
| $469K | 0.01% |
224,501
-8,655
| -4% | -$17.9K |
|
1623
Constellation Brands
STZ
$23.1B
| $469K | 0.01% |
2,024
+1,015
| +101% | +$243K |
|
1624
Oil States International
OIS
$500M
| $467K | 0.01% |
62,535
-66,446
| -52% | -$411K |
|
1625
RE/MAX Holdings
RMAX
$263M
| $467K | 0.01% |
25,060
+6,345
| +34% | +$121K |
|
Similar funds
Paul Tudor Jones's Q4 2022 Portfolio in Review
As of Q4 2022, Paul Tudor Jones held 3,056 positions worth $5.06B, up 9.2% from $4.63B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Paul Tudor Jones deployed $198M of net new capital in Q4 2022, opening 801 new positions and adding to 766 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $39M trimmed.
- Paul Tudor Jones's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
- Paul Tudor Jones added most to Coupa Software Incorporated in Q4 2022, an estimated $32.1M increase.
- Paul Tudor Jones's biggest Q4 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $39M.
- Paul Tudor Jones fully exited Alleghany Corp in Q4 2022, selling an estimated $93.4M.
- Paul Tudor Jones's ten largest holdings make up 9.1% of its $5.06B portfolio in Q4 2022.
- Paul Tudor Jones opened 801 new positions and closed 756 in Q4 2022.
- Paul Tudor Jones's portfolio value rose 9.2% quarter-over-quarter to $5.06B.
Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.